Open AccessGuselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Author(s) -
Andrea Chiricozzi,
Antonio Costanzo,
Maria Concetta Fargnoli,
Piergiorgio Malagoli,
Stefano Piaserico,
Paolo Amerio,
Giuseppe Argenziano,
Nicola Balato,
Federico Bardazzi,
Luca Bianchi,
Carlo Giovanni Carrera,
Andrea Conti,
Paolo Dapavo,
Clara De Simone,
Francesco Loconsole,
Ada Lo Schiavo,
Giovanna Malara,
Maria Letizia Musumeci,
Aurora Parodi,
Ketty Peris,
Francesca Prignano,
Franco Rongioletti,
Marina Talamonti,
Concetta Potenza
Publication year - 2021
Publication title -
european journal of dermatology/ejd. european journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2021.3965
Subject(s) - medicine , ustekinumab , secukinumab , psoriasis , dermatology , psoriatic arthritis , interleukin 23 , tolerability , clinical trial , adalimumab , immunology , disease , adverse effect , immune system , interleukin 17